Illumina lowers Outlook due to China sales ban
China bans sales of Illumina DNA sequencers as Trump escalates global tariffs
Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country.
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...
At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.
Illumina said at the time that it was working to find a solution. “We respect and abide by Chinese laws and regulations,” the ...
Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...
Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic ...
Last month Illumina shareholders received a warning shot. In response to President Trump’s initial tariff measures, the Chinese government added the maker of gene-sequencing equipment to its ...
Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback